Delay in Forest Drug FDA Action Date – Analyst Blog – NASDAQ

The company recently announced that the US Food and Drug Administration (FDA) has extended its action date for aclidinium bromide by three months. Forest Labs and partner Almirall are looking to get aclidinium bromide approved for the maintenance treatment …

Leave a Reply

Your email address will not be published. Required fields are marked *

*